These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 27613346)

  • 1. The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders.
    Hammond CJ
    Child Adolesc Psychiatr Clin N Am; 2016 Oct; 25(4):685-711. PubMed ID: 27613346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy of adolescent substance use disorders: a review of the literature.
    Waxmonsky JG; Wilens TE
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):810-25. PubMed ID: 16262597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment development and feasibility study of family-focused treatment for adolescents with bipolar disorder and comorbid substance use disorders.
    Goldstein BI; Goldstein TR; Collinger KA; Axelson DA; Bukstein OG; Birmaher B; Miklowitz DJ
    J Psychiatr Pract; 2014 May; 20(3):237-48. PubMed ID: 24847999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingency Management with pharmacologic treatment for Stimulant Use Disorders: A review.
    Tardelli VS; Lago MPPD; Mendez M; Bisaga A; Fidalgo TM
    Behav Res Ther; 2018 Dec; 111():57-63. PubMed ID: 30316027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and examination of the attribution questionnaire-substance use disorder (AQ-SUD) to measure public stigma towards adolescents experiencing substance use disorders.
    Johnson-Kwochka A; Aalsma MC; Monahan PO; Salyers MP
    Drug Alcohol Depend; 2021 Apr; 221():108600. PubMed ID: 33689966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Pharmacotherapy and Cognitive Behavioral Therapy for Adults With Alcohol or Substance Use Disorders: A Systematic Review and Meta-analysis.
    Ray LA; Meredith LR; Kiluk BD; Walthers J; Carroll KM; Magill M
    JAMA Netw Open; 2020 Jun; 3(6):e208279. PubMed ID: 32558914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy interventions for adolescent co-occurring substance use and mental health disorders: a systematic review.
    Scott K; Becker SJ; Helseth SA; Saldanha IJ; Balk EM; Adam GP; Konnyu KJ; Steele DW
    Fam Pract; 2022 Mar; 39(2):301-310. PubMed ID: 34448853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for substance abuse disorders in adolescence.
    Kaplan G; Ivanov I
    Pediatr Clin North Am; 2011 Feb; 58(1):243-58, xiii. PubMed ID: 21281859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Eur Addict Res; 2020; 26(4-5):223-232. PubMed ID: 32634814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Pharmacotherapy of Childhood-Onset Psychiatric Disorders on the Development of Substance Use Disorders.
    Wilens TE; Woodward DW; Ko JD; Berger AF; Burke C; Yule AM
    J Child Adolesc Psychopharmacol; 2022 May; 32(4):200-214. PubMed ID: 35587209
    [No Abstract]   [Full Text] [Related]  

  • 12. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New medication strategies for comorbid substance use and bipolar affective disorders.
    Kosten TR; Kosten TA
    Biol Psychiatry; 2004 Nov; 56(10):771-7. PubMed ID: 15556122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans.
    Kraemer KL; McGinnis KA; Fiellin DA; Skanderson M; Gordon AJ; Robbins J; Zickmund S; Bryant K; Korthuis PT
    J Subst Abuse Treat; 2019 Aug; 103():23-32. PubMed ID: 31229189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical dilemma of using medications in substance-abusing adolescents and adults with attention-deficit/hyperactivity disorder: what does the literature tell us?
    Wilens TE; Monuteaux MC; Snyder LE; Moore H; Whitley J; Gignac M
    J Child Adolesc Psychopharmacol; 2005 Oct; 15(5):787-98. PubMed ID: 16262595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological interventions for co-occurring depression and substance use disorders.
    Hides L; Quinn C; Stoyanov S; Kavanagh D; Baker A
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31769015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dual diagnosis psychosis and substance use disorders in adolescents--part 2].
    Meister K; Rietschel L; Burlon M; Gouzoulis-Mayfrank E; Bock T; Lambert M
    Fortschr Neurol Psychiatr; 2010 Feb; 78(2):90-100. PubMed ID: 20146153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy for Substance Use Disorders in Youths.
    Hammond CJ; Gray KM
    J Child Adolesc Subst Abuse; 2016; 25(4):292-316. PubMed ID: 28082828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Treatment of Youth Substance Use Disorders.
    Squeglia LM; Fadus MC; McClure EA; Tomko RL; Gray KM
    J Child Adolesc Psychopharmacol; 2019 Aug; 29(7):559-572. PubMed ID: 31009234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.